Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01973101Phase 2Unknown
A Phase 2 trial of gemcitabine in Cervical Cancer (CC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01973101.